Abstract: . . .  will drive a new trend toward individualizing hypertension treatment for each patient. About CardioDynamics: CardioDynamics (Nasdaq: CDIC), the ICG Company, is the innovator and leader of an important medical technology called impedance . . .
. . .  Cindy Presar, Investor Relations cpresar@cardiodynamics.com 800-778-4825 Ext. 1031 CardioDynamics Announces Publication of Multicenter Hypertension CONTROL Trial Published in Hypertension , an American Heart . . .
. . .  2006--CardioDynamics (Nasdaq: CDIC), the innovator and leader of impedance cardiography (ICG) technology, today announced the publication of its multicenter, randomized trial called CONTROL (Consideration Of Noninvasive Hemodynamic Monitoring . . .
. . .  CDIC), the innovator and leader of impedance cardiography (ICG) technology, today announced the publication of its multicenter, randomized trial called CONTROL (Consideration Of Noninvasive Hemodynamic Monitoring To Target Reduction Of Blood . . .
. . .  release contains forward-looking statements, such as what evidence Medicare uses in its review of whether to expand hypertension coverage for BioZ ICG, the accuracy of which is necessarily subject to uncertainties and risks including the . . .
--1285,5,128,1668,6427